CBD ‘CBD Nation’ doc aims to treat stigma with medical success stories Director and producer David Jakubovic says stigma can be broken with just 5 minutes of being open to science Michelle GamageAugust 13, 2020
Canada Vapes lead 2.0 market share in Canada, gummies set to rise: Headset Data suggest gummies are primed to increase sales share and there's opportunity for new brands to enter the space Nick LabaAugust 13, 2020
Canada One-third of BC’s legal weed consumers buy online: survey The trend emphasizes the need for online product info, which can cause a consumer to jump if not available, says branding expert Nick LabaAugust 11, 2020
Health and Safety American Heart Association calls for deschechuling weed to improve research A recent review found use could negatively impact heart health, but laws impeding research means there's a lack of hard evidence Michelle GamageAugust 7, 2020
Canada ‘It actually works’: Vancouver study shares stories of youth choosing weed over harder drugs Authors of the rare qualitative research say health services must incorporate evidence that cannabis can reduce more harmful substance use Nick LabaJuly 30, 2020
CBD FDA issues cannabis research guidelines as CBD industry still hangs in limbo Vermont cannabis lawyer Timothy Fair calls FDA's two-year delay on CBD regulations 'beyond absurd' Jared GnamJuly 24, 2020
Analysis Record cannabis sales not driven by increased store count: StatsCan General Covid-related spending habits appear to be responsible for the trend Nick LabaJuly 22, 2020
Cannabis 2.0 Creating cannabinoids from yeast: why it could mean trouble for extractors Biosynthetic cannabinoids use a fraction of extraction's cost, energy, water and biomass waste Michelle GamageJune 19, 2020
Data Only 3% of Australians using medical weed get it from licit market: study Complaints of inadequate regulatory framework and prohibitive cost mirror criticisms in Canada Michelle GamageJune 17, 2020
Psychedelics Numinus licensed by Health Canada to extract and research psilocybin Extracting psilocybin from magic mushrooms will be cheaper than current method of creating synthetic compound for research, says company Michelle GamageJune 12, 2020